Stocks of Johnson & Johnson - Current price, Where to buy? Dividends
Detail | Data |
---|---|
Stocks: | Johnson & Johnson |
ompany Name: | Johnson & Johnson |
Ticker: | JNJ |
Exchange: | NYSE |
Outstanding stocks: | 2,406,680,064 |
24-hour Volume: | 6,356,614 |
Industry: | Drug Manufacturers - General |
Sector: | Healthcare |
Number of Employees: | 131900 |
Country: | United States |
City: | New Brunswick |
Address: | One Johnson & Johnson Plaza |
P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
---|---|---|---|---|---|
22.18 | 13.63 | 6.73 USD | 10.95 USD | 29.09 USD | 359,245,152,256.00 USD |
P/E Ratio: | 22.18 |
---|---|
Forward P/E: | 13.63 |
EPS: | 6.73 USD |
Forward EPS: | 10.95 |
Book value per share: | 29.09 USD |
Market capitalization: | 359,245,152,256.00 USD |
Johnson & Johnson
Fundamental Indicators
Indicator | Data |
---|---|
Total Revenue: | 85,647,998,976.00 USD |
Net Income: | 17,072,000,000.00 USD |
Price-to-Book (P/B) Ratio: | 5.13 |
PEG Ratio: | 3.1 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
Analysts | Recommendation |
---|---|
Issued Recommendation: | According to our data, the recommendation issued for Johnson & Johnson stocks is: buy |
Number of Analysts: | 22 |
Highest Target Price: | 200.32 USD |
Lowest Target Price: | 144.41 USD |
Average Target Price: | 158.39 USD |
Note: The data is approximate. Recommendations and price forecasts for Johnson & Johnson stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
Dividends | Value |
---|---|
Dividend Amount | Company Johnson & Johnson pays a dividend of 4.96 USD per share. |
Annual Yield %: | 3.32 % |
Ex-dividend Date: | 2024-05-20 |
Average % Yield for 5 Years: | 2.68 % |
Payout Ratio: | 70.73 % |
Value of Last Dividend Paid: | 1.19 USD |
Date of Last Dividend: | 2024-02-16 |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Johnson & Johnson Stocks?
If you're interested in investing in Johnson & Johnson stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Johnson & Johnson stocks through mobile apps with client support. In this table, you can compare brokers offering real Johnson & Johnson stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
---|---|---|---|---|---|---|---|
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller | Go to eToro | ||||
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer | Go to XTB |
xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
Go to XTB | Go to eToro |
More Information about Johnson & Johnson (JNJ)
Johnson & Johnson consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 85,647,998,976.00 USD, demonstrating its strong market position and ability to generate high revenues. With EBITDA reaching 30,606,000,128.00 USD, Johnson & Johnson maintains a high level of efficiency and profitability. This highlights its ability to manage operational costs effectively. Debt-to-equity ratio of 0.48 suggests that Johnson & Johnson has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 69.33% shows that Johnson & Johnson efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Profit margin of 44.92% underscores Johnson & Johnson's efficiency in converting revenues into net income, which is crucial for its prosperity.
Indicator | Value |
---|---|
Revenue, Debt, and Cash Flow | |
Company Revenue: | 85,647,998,976.00 USD |
EBITDA: | 30,606,000,128.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
Earnings Per Share: | 6.73 USD |
Book Value Per Share: | 29.09 USD |
Total Cash: | 26,218,000,384.00 USD |
Total Cash per Share: | 10.89 USD |
Total Debt: | 33,632,000,000.00 USD |
Debt to Equity Ratio: | 0.48 |
Quick Ratio: | 0.85 |
Current Ratio: | 1.17 |
Free Cash Flow: | 24,294,125,568.00 USD |
Operating Cash Flow: | 23,190,999,040.00 USD |
Company Margins | |
Gross Margins: | 69.33 % |
EBITDA Margins: | 35.74 % |
Operating Margins: | 29.48 % |
Profit Margins: | 44.92 % |
Performance | |
Return on Assets: | 8.0 % |
Return on Equity: | 24.2 % |
Earnings Growth (1 year): | / |
Revenue Growth (1 year): | 2.3 % |
Year-over-Year Quarterly Earnings Growth: | / |
Valuation | |
Market Capitalization: | 359,245,152,256.00 USD |
Enterprise Value: | 366,659,010,560.00 USD |
EV/Revenue: | 4.281 |
EV/EBITDA: | 11.98 |
Number of Shares and Short Shares | |
Float Shares: | 2,401,913,958 shares |
Shares Outstanding: | 2,406,680,064 shares |
Held Percent Insiders: | 0.00 % |
Held Percent Institutions: | 71.25 % |
Shares Short: | 16,563,652 |
Shares Short Prior Month: | 15,839,005 |
Date Short Interest: | 2024-04-15 |
Shares Percent Shares Out: | 0.69 % |
Short Ratio: | 2.30 |
Beta: | 0.53 |
Short Percent of Float: | 0.69 % |
Předpokládaný počet akcií: | 2,417,159,936 |
Frequently Asked Questions (FAQ)
The company Johnson & Johnson pays a dividend of 4.96 USD per share. At this rate, the annual yield is 3.32 %.
Johnson & Johnson shares are traded on the stock exchange NYSE under the ticker symbol: JNJ. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for Johnson & Johnson shares by a total of 22 analysts. The average target price prediction is 158.39 USD per share.
The total number of Johnson & Johnson shares on the exchange is 2,406,680,064.00, which, at the current market capitalization, values the company at 359,245,152,256.00 USD.